Request Deal Involvement

Novartis to acquire Avidity Biosciences for $12bn.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Goldman Sachs

financial advisors

Goldman Sachs

Barclays

financial advisors

Barclays

Kirkland & Ellis

legal advisors

Kirkland & Ellis

Joele Frank

pr advisors

Joele Frank

Sullivan & Cromwell

legal advisors to financial advisors

Sullivan & Cromwell

Covington & Burling

legal advisors

Covington & Burling

or

Principals

AVIDITY BIOSCIENCES INC

target

AVIDITY BIOSCIENCES INC

NOVARTIS AG

bidder

NOVARTIS AG

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Novartis to acquire Avidity Biosciences for $12bn.